经月经检测市场规模、份额及成长分析（按产品类型、治疗类型、最终用户和地区）—产业预测，2025 年至 2032 年

2023 年全球经月经检测市场规模为 36 亿美元，预计将从 2024 年的 38.9 亿美元成长到 2032 年的 72.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.1%。

由于月经盛行率的不断上升、人们对月经健康的认识不断提高以及诊断技术的进步，全球月经检测市场正在经历显着增长。月经疼痛的广泛影响导致寻求临床评估的患者增加，从而增加了对检测服务的需求。政府推出的支持性政策资助了月经卫生倡议，也增加了月经检测的机会。生殖健康诊所的增加和人们对不孕症治疗的兴趣日益浓厚，进一步促进了检测需求的成长。此外，人工智慧和机器学习等技术创新有助于分析患者数据，以便在早期预测月经，而物联网设备则有助于在月经期间持续监测生命体征，最终改变月经诊断和管理的模式。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 顾客购买行为分析

经月经检测市场规模（依产品类型及复合年增长率）（2025-2032）

• 市场概览
• 原发性经痛检查
• 续发性月经检查

经月经检测市场规模（依治疗类型及复合年增长率）（2025-2032）

• 市场概览
• 止痛药
• 荷尔蒙疗法
• 外科手术

经月经检测市场规模（依最终用户划分）及复合年增长率（2025-2032）

• 市场概览
• 医院和诊所
• 研究中心

经月经检测市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• Pfizer Inc.
• Bayer AG
• Johnson & Johnson Services, Inc.
• Quin
• Abbott Laboratories
• Merck & Co., Inc.
• Global Pharma plc
• Mylan NV
• Teva Pharmaceutical Industries Ltd.
• Proteomics Inc.
• Boehringer Ingelheim International GmbH
• Ferring Pharmaceuticals

结论和建议

Global Dysmenorrhea Testing Market size was valued at USD 3.6 billion in 2023 and is poised to grow from USD 3.89 billion in 2024 to USD 7.26 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global dysmenorrhea testing market is experiencing significant growth, driven by the increasing prevalence of dysmenorrhea, heightened awareness of menstrual health, and advancements in diagnostic technologies. More patients are seeking clinical evaluations due to the widespread impact of menstrual pain, which boosts demand for testing services. Enhanced access to dysmenorrhea testing is also attributed to supportive government policies that fund menstrual health initiatives. The rise in reproductive health clinics and a growing focus on fertility are further contributing to the uptick in testing. Additionally, innovations such as AI and machine learning help analyze patient data to predict dysmenorrhea early, while IoT devices facilitate continual monitoring of vital signs during menstruation, ultimately transforming the landscape of dysmenorrhea diagnosis and management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dysmenorrhea Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dysmenorrhea Testing Market Segments Analysis

Global Dysmenorrhea Testing Market is segmented by Product Type, Type of Treatment, End User and region. Based on Product Type, the market is segmented into Primary Dysmenorrhea Testing and Secondary Dysmenorrhea Testing. Based on Type of Treatment, the market is segmented into Pain Relievers, Hormonal Therapy and Surgery. Based on End User, the market is segmented into Hospitals and Clinics and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dysmenorrhea Testing Market

The rising prevalence of both primary and secondary dysmenorrhea, coupled with an increased inclination among women to seek healthcare for chronic or severe menstrual pain, is driving the demand for dysmenorrhea testing. As more individuals pursue clarity regarding their conditions, the need for accurate diagnostics becomes essential. Moreover, heightened awareness and advocacy from governmental bodies and non-governmental organizations focused on women's health further promote the importance of medical screenings for menstrual disorders. This growing emphasis on health and well-being ultimately contributes to a burgeoning market for dysmenorrhea testing solutions, reflecting a significant shift towards proactive healthcare management in this area.

Restraints in the Global Dysmenorrhea Testing Market

The Global Dysmenorrhea Testing market faces significant challenges stemming from cultural stigmas surrounding menstruation, which often discourage open discussion and restrict access to necessary menstrual health services. In conservative societies, women frequently experience limitations on their autonomy, which can hinder their ability to pursue healthcare options or prioritize their well-being, particularly when their pain is minimized or dismissed. Moreover, there can be a tendency among healthcare providers to overlook or undervalue the symptoms reported by patients due to existing gender biases, ultimately detracting from the quality of care and the effectiveness of testing for dysmenorrhea.

Market Trends of the Global Dysmenorrhea Testing Market

The Global Dysmenorrhea Testing market is witnessing a significant upward trend driven by an increase in awareness surrounding menstrual health and the importance of early diagnosis. Government initiatives and nonprofit educational campaigns are effectively breaking the stigma associated with menstrual disorders, encouraging women to pursue dysmenorrhea testing and subsequent care. This heightened health awareness is propelling the demand for innovative testing solutions, including hormonal profiling, ultrasound diagnostics, and advanced deep learning scans that offer personalized assessments. As more women engage with healthcare providers regarding their menstrual health, the market is poised for sustained growth, reflecting a broader societal commitment to women's health and wellbeing.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Dysmenorrhea Testing Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Primary Dysmenorrhea Testing
• Secondary Dysmenorrhea Testing

Global Dysmenorrhea Testing Market Size by Type of Treatment & CAGR (2025-2032)

• Market Overview
• Market Overview
• Pain Relievers
• Hormonal Therapy
• Surgery

Global Dysmenorrhea Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Research Centers

Global Dysmenorrhea Testing Market Size & CAGR (2025-2032)

• North America (Product Type, Type of Treatment, End User)
  • US
  • Canada
• Europe (Product Type, Type of Treatment, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type of Treatment, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type of Treatment, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type of Treatment, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Pharma plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteomics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations